Try our beta test site
24 studies found for:    Northwestern AND Pulmonary fibrosis
Show Display Options
Rank Status Study
1 Recruiting Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
Conditions: Interstitial Lung Disease;   ILD;   Systemic Sclerosis;   Scleroderma
Interventions: Drug: Bortezomib;   Drug: Placebo;   Drug: Mycophenolate mofetil
2 Active, not recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
3 Terminated A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Simtuzumab (GS-6624);   Drug: Placebo to match simtuzumab
4 Completed
Has Results
Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
Condition: Scleroderma
Intervention: Drug: dasatinib
5 Recruiting Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Interventions: Drug: Inhaled Treprostinil;   Drug: Placebo
6 Enrolling by invitation An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Intervention: Drug: Inhaled Treprostinil
7 Active, not recruiting A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
Condition: Bronchiolitis Obliterans
Intervention: Drug: Bortezomib
8 Completed Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Xylitol;   Drug: Xylo-pentane-1,2,3,4 5-pentol
9 Completed Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: Vancomycin inhalation powder;   Drug: Placebo inhalation powder
10 Completed
Has Results
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg two times a day (BID)/three times a day (TID);   Drug: Placebo two times a day (BID)/three times a day (TID)
11 Completed
Has Results
International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg three times a day (TID);   Drug: Placebo three times a day (TID)
12 Recruiting A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)
Condition: Cystic Fibrosis
Interventions: Drug: Gallium nitrate;   Drug: Normal Saline
13 Completed Infant Study of Inhaled Saline in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: 7% Hypertonic Saline (HS);   Drug: 0.9% Isotonic Saline (IS)
14 Recruiting Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With CF
Condition: Cystic Fibrosis
Interventions: Drug: azithromycin;   Drug: placebo (for azithromycin);   Drug: inhaled tobramycin
15 Unknown  Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
Conditions: Lung Cancer;   Pulmonary Complications;   Radiation Fibrosis
Intervention: Drug: captopril
16 Not yet recruiting Urinary and Anorectal Functional Disorders and Their Impact on CF Adults (PerineoMucoRMO)
Condition: Cystic Fibrosis
Intervention:
17 Completed Long Term Administration of Inhaled Mannitol in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: inhaled mannitol;   Drug: Placebo comparator
18 Completed
Has Results
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Conditions: Scleroderma;   Interstitial Lung Disease
Interventions: Drug: Mycophenolate mofetil;   Drug: Cyclophosphamide;   Drug: Placebo
19 Recruiting Genetic Modifiers of Cystic Fibrosis Related Diabetes
Condition: Cystic Fibrosis Related Diabetes
Intervention:
20 Recruiting Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: QR-010;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.